Standout Papers
- Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial (2000)
- Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study (2000)
Immediate Impact
1 by Nobel laureates 10 from Science/Nature 79 standout
Citing Papers
Pan-cancer whole-genome comparison of primary and metastatic solid tumours
2023 StandoutNature
Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial
2023 Standout
Works of Alan Webster being referenced
Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
2014
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alan Webster | 3368 | 2485 | 3337 | 2651 | 33 | 5.7k | |
| Dean B. Evans | 2103 | 986 | 2686 | 2003 | 106 | 5.5k | |
| Ivana Šestak | 3202 | 1287 | 3976 | 3962 | 107 | 7.3k | |
| Mark L. Steinberg | 1973 | 777 | 1456 | 1381 | 50 | 3.3k | |
| Elizabeth Tan-Chiu | 3109 | 1042 | 5057 | 3183 | 47 | 8.5k | |
| M Baum | 2328 | 565 | 2001 | 1558 | 33 | 3.5k | |
| Hideki Endoh | 1717 | 2718 | 2838 | 2426 | 52 | 7.5k | |
| D. Craig Allred | 2348 | 908 | 4448 | 3363 | 51 | 7.4k | |
| Tommy� Fornander | 2051 | 1166 | 2833 | 2556 | 133 | 6.4k | |
| T.J. Powles | 3339 | 687 | 3718 | 2311 | 81 | 6.8k | |
| Janet Wolter | 1252 | 2290 | 9010 | 2869 | 30 | 12.1k |
All Works
Loading papers...